Transphorm Inc.

NASDAQ: TGAN · Real-Time Price · USD
5.10
0.34 (7.14%)
At close: Jun 20, 2024, 10:00 PM

Transphorm Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2023 Mar 31, 2022 Dec 31, 2020
Revenue
16.51M 24.05M 11.37M
Cost of Revenue
17.46M 12.53M 6.68M
Gross Profit
-950K 11.52M 4.69M
Operating Income
-28.78M -9.9M -13.4M
Interest Income
n/a n/a n/a
Pretax Income
-30.6M -10.23M -17.91M
Net Income
-31.69M -10.57M -22.42M
Selling & General & Admin
18.92M 14.76M 12.5M
Research & Development
8.91M 6.66M 5.58M
Other Expenses
n/a n/a n/a
Operating Expenses
27.83M 21.42M 18.09M
Interest Expense
730K 792K 760K
Selling & Marketing Expenses
5.25M 3.54M 2.17M
Cost & Expenses
45.29M 33.95M 24.77M
Income Tax Expense
1.09M 339K 4.51M
Shares Outstanding (Basic)
56.23M 46.06M 31.74M
Shares Outstanding (Diluted)
56.23M 46.06M 31.74M
EPS (Basic)
-0.56 -0.23 -0.71
EPS (Diluted)
-0.56 -0.23 -0.71
EBITDA
-28.33M -8.6M -16.31M
EBIT
-28.78M -9.9M -13.4M
Depreciation & Amortization
443K 1.29M -2.92M